Syntax Research’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.9K Hold
300
0.01% 127
2026
Q1
$22.6K Hold
300
0.01% 122
2025
Q4
$18.5K Hold
300
0.01% 125
2025
Q3
$17.6K Hold
300
0.01% 125
2025
Q2
$17.5K Sell
300
-60,118
-100% -$3.4M 0.01% 117
2025
Q1
$3M Sell
60,418
-2,416
-4% -$124K 2.07% 19
2024
Q4
$2.81M Sell
62,834
-2,002
-3% -$95K 2.02% 21
2024
Q3
$3.12M Buy
64,836
+6,637
+11% +$320K 2.1% 20
2024
Q2
$2.96M Sell
58,199
-4,209
-7% -$230K 2.34% 20
2024
Q1
$3.39M Buy
62,408
+15,884
+34% +$828K 2.59% 13
2023
Q4
$2.62M Buy
46,524
+16,262
+54% +$919K 2.19% 17
2023
Q3
$1.87M Buy
+30,262
New +$1.91M 1.51% 24

Other funds holding NTR

Syntax Research's NTR Position: Q2 2026 in Review

Syntax Research held its Nutrien (NTR) position steady in Q2 2026 at 300 shares worth $18.9K. The position accounts for 0.01% of the portfolio, ranked #127.

Syntax Research first reported a position in NTR in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.39M in Q1 2024. 728 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Syntax Research held 300 shares of Nutrien worth $18.9K as of Q2 2026.
  • Syntax Research left its Nutrien share count unchanged in Q2 2026.
  • Nutrien made up 0.01% of Syntax Research's portfolio in Q2 2026, its #127 holding.
  • Syntax Research first reported a position in Nutrien in Q3 2023 and has held it in 12 quarters since.
  • Syntax Research's Nutrien position peaked at $3.39M in Q1 2024.
  • 728 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.